Disc Medicine amends loan with Hercules, draws $30M, extends draw periods

Disc Medicine, Inc.

Drew $30M of Tranche 1-B advance under existing loan agreement with Hercules Capital.
Existing $50M Tranche 1-C split into $25M available through March 31, 2027 and $25M Tranche 1-D through April 30, 2027.
Tranche 2 and Tranche 3 draw periods extended to December 15, 2027 and June 30, 2028, respectively.
Minimum cash covenant testing date moved to July 1, 2028.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.